Parasite Epidemiology and Control

PARASITE EPIDEMIOLOGY AND CONTROL AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX <ul style="display: flex;"><li style="flex:1">.</li><li style="flex:1">.</li></ul>•••• <a href="#1_0">Description </a><a href="#1_1">Abstracting and Indexing </a><a href="#1_2">Editorial Board </a>p.1 p.1 p.1 <ul style="display: flex;"><li style="flex:1">p.4 </li><li style="flex:1"><a href="#4_0">Guide for Authors </a></li></ul>ISSN: 2405-6731 DESCRIPTION .Parasite Epidemiology and Control is an Open Access journal. There is increased parasitology research that analyses the patterns, causes, and effects of health and disease conditions in defined populations. This epidemiology of parasite infectious diseases is predominantly studied in human populations but also includes other major hosts of parasitic infections and as such this journal has broad remit. Parasite Epidemiology and Control focuses on the major areas of epidemiological study including disease etiology, disease surveillance, drug resistance, geographical spread, screening, biomonitoring, and comparisons of treatment effects in clinical trials for both human and other animals. We also focus on the epidemiology and control of vector insects. The journal also covers the use of geographic information systems (Epi-GIS) for epidemiological surveillance which is a rapidly growing area of research in infectious diseases. Molecular epidemiological approaches are also particularly encouraged. ABSTRACTING AND INDEXING .PubMed Central Directory of Open Access Journals (DOAJ) Google Scholar ScienceDirect Scopus EDITORIAL BOARD .Founding Editor Marcel Tanner, Swiss Tropical and Public Health Institute, Basel, Switzerland Epidemiology and control, health systems, one-health, global public health Editors Uwemedimo Friday Ekpo, Federal University of Agriculture Abeokuta Department of Pure and Applied Zoology, Abeokuta, Nigeria Tropical Parasitic Diseases, Schistosomiasis, Malacology, Vector Control, Epidemiological Disease Mapping, Behavioral Changes, One health Pikka Jokelainen, State Serum Institute, Department of Bacteria, Parasites and Fungi, Infectious Disease Preparedness, Laboratory of Parasitology, Copenhagen, Denmark <ul style="display: flex;"><li style="flex:1">AUTHOR INFORMATION PACK 27 Sep 2021 </li><li style="flex:1"><a href="/goto?url=http://www.elsevier.com/locate/parepi" target="_blank">www.elsevie</a><a href="/goto?url=http://www.elsevier.com/locate/parepi" target="_blank">r</a><a href="/goto?url=http://www.elsevier.com/locate/parepi" target="_blank">.</a><a href="/goto?url=http://www.elsevier.com/locate/parepi" target="_blank">com/locate/parepi </a></li><li style="flex:1">1</li></ul>Zoonotic parasites, Toxoplasma gondii, One health Olumide Ogundahunsi, University of Medical Sciences, Ondo, Nigeria Tropical diseases, malaria, implementation research, pharmacology &, therapeutics Juan David Ramírez, Universidad del Rosario, Center for Research in Microbiology and Biotechnology-UR (CIMBIUR), Bogota, Colombia Chagas disease, leishmaniasis, intestinal parasites, disease ecology, molecular diagnosis, disease evolution, genomics, transcriptomics Tai-Soon Yong, Yonsei University Institute of Tropical Medicine, Seoul, South Korea Systematics, ecology and the control of disease vectors, diagnosis technologies Editorial Board Members Jean Louis Abdourahim Ndiaye, University of Thies, Thies, Senegal Malaria epidemiology and control, public health, malaria in pregnancy, seasonal malaria chemoprevention Jeffrey M. Bethony, The George Washington University, Washington, District of Columbia, United States of America Vaccines, cancer biomarkers, biobanking and biorepositories, clinical trials, HIV/AIDS, HIV/AIDsassociated malignancies Fred Binka, World Health Organization Representative Office Cambodia, Phnom Penh, Cambodia Clinical epidemiology, infectious disease epidemiology, measurement Pascal Boireau, National Agency for Food Environmental and Occupational Health and Safety, Maisons Alfort, France Foodborne parasites Jong-Yil Chai, Seoul National University College of Medicine Department of Tropical Medicine and Parasitology, Seoul, South Korea Intestinal parasites, Diagnostic parasitology, Zoonotic trematodes, Clinical parasitology, Toxoplasmosis and Cryptosporidiosis Alan Cowman, Walter and Eliza Hall Institute of Medical Research Infectious Diseases and Immune Defence Division, Parkville, Victoria, Australia Malaria, cell biology, vaccine and anti-malarial drug development Liwang Cui, The Pennsylvania State University, University Park, United States of America Malaria functional genomics, drug devleopment, epidemiology and control Ananias Escalante, Temple University, Philadelphia, Pennsylvania, United States of America Molecular epidemiology of infectious diseases, disease ecology, evolutionary genetics, comparative genomics Marcelo Urbano Ferreira, University of Sao Paulo, São Paulo, Brazil Malaria epidemiology and control, population genetics of malaria parasites, naturally acquired immunity to parasites Felipe Guhl, University of Los Andes Department of Biological Sciences, Bogotá, Colombia Tropical Parasitology, neglected diseases, molecular biology, control strategies, chagas disease Peter Hotez, Baylor College of Medicine, Houston, Texas, United States of America Vaccinology, neglected tropical diseases, public policy, hookworm, coronavirus Panagiotis Karanis, University of Cologne, Cologne, Germany Water, Food, Vector, Airborne Parasitic and Tropical Diseases Jacob Koella, University of Neuchâtel, Neuchatel, Switzerland Theoretical epidemiology, evolutionary ecology of parasites, malaria-mosquito interactions Kwadwo Koram, University of Ghana Noguchi Memorial Institute for Medical Research, Accra, Ghana Malaria epidemiology and control, drug resistance Jørgen A. L. Kurtzhals, University of Copenhagen, Copenhagen, Denmark Malaria pathogenesis and treatment, parasite diagnostics, interactions between nutrition and infections, infection control, international health Marcus Lacerda, University of Amazonas State, MANAUS, Brazil Infectious diseases, Plasmodium vivax, anti-malarial drugs Shi-Zhu Li, National Institute of Parasitic Diseases, Shanghai, China Parasitic Disease Control, Schistosomiasis Control, epidemiology, phylogenetic, snail population genetics Lisette van Lieshout, Leiden University Medical Center Department of Parasitology, Leiden, Netherlands Epidemiology and control, health systems, one-health, global public health Santiago Mas-Coma, University of Valencia, Valencia, Spain Neglected tropical diseases, helminthic diseases, food-borne trematodiases, fascioliasis, vector-borne diseases, molluscan and arthropod vectors Donald P McManus, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia <ul style="display: flex;"><li style="flex:1">AUTHOR INFORMATION PACK 27 Sep 2021 </li><li style="flex:1"><a href="/goto?url=http://www.elsevier.com/locate/parepi" target="_blank">www.elsevie</a><a href="/goto?url=http://www.elsevier.com/locate/parepi" target="_blank">r</a><a href="/goto?url=http://www.elsevier.com/locate/parepi" target="_blank">.</a><a href="/goto?url=http://www.elsevier.com/locate/parepi" target="_blank">com/locate/parepi </a></li><li style="flex:1">2</li></ul>Schistosomiasis, Echinocococcosis, Intestinal worm infections, Diagnostics, Vaccines, Epidemiology, Health education João Mesquita, University of Porto Institute of Biomedical Sciences Abel Salazar, Porto, Portugal Molecular biology, epidemiology, vector-borne diseases Francine Ntoumi, Congolese Foundation for Medical Research, Brazzaville, Congo Malaria immunology and molecular epidemiology, infectious diseases David Piedrafita, Federation University Australia School of Science Engineering and Information Technology Gippsland, Churchill, Australia Immunology, vaccine development, Fasciola, veterinary parasitology Men-Bao Qian, Chinese Center for Disease Control and Prevention, Beijing, China Epidemiology and statistics, Helminthiases, Food-borne trematodiasis, Soil-transmitted helminthiasis, Taeniasis and cysticercosis Antonieta Rojas de Arias, Center for the Development of Scientific Research, Asuncion, Paraguay Chagas disease, Leishmaniasis, Malaria, Climate change, Ecoepidemiology David Rollinson, Natural History Museum, London, United Kingdom Schistosomiasis, control and elimination of neglected tropical diseases, population genetics and evolution Christen Rune Stensvold, State Serum Institute, København, Denmark Molecular epidemiology, diagnostics, intestinal Parasites, genetic diversity, microbiome Sue Welburn, The University of Edinburgh, Edinburgh, United Kingdom Neglected zoonotic diseases, one health, epidemiology, molecular epidemiology Zhong Dao Wu, Sun Yat-Sen University, Guangzhou, China Helminths, Schistosoma, epidemiology and control Guiyan Yan, University of California Irvine, Irvine, California, United States of America Vector-borne disease epidemiology, vector biology, malaria Xiao-Nong Zhou, National Institute of Parasitic Diseases, Shanghai, China Tropical diseases, Schistosomiasis, Malaria, Malacology, One health, Global health, Implementation research, Epidemiology, Modeling Xing-Quan Zhu, Shanxi Agricultural University, College of Veterinary Medicine, Taigu, China Parasite epidemiology, Diagnostics and control strategies, Parasite genetics, Genomics and functional omics, Molecular vaccines <ul style="display: flex;"><li style="flex:1">AUTHOR INFORMATION PACK 27 Sep 2021 </li><li style="flex:1"><a href="/goto?url=http://www.elsevier.com/locate/parepi" target="_blank">www.elsevie</a><a href="/goto?url=http://www.elsevier.com/locate/parepi" target="_blank">r</a><a href="/goto?url=http://www.elsevier.com/locate/parepi" target="_blank">.</a><a href="/goto?url=http://www.elsevier.com/locate/parepi" target="_blank">com/locate/parepi </a></li><li style="flex:1">3</li></ul>GUIDE FOR AUTHORS .INTRODUCTION There is an increasing amount of research in the parasitology area that analyses the patterns, causes, and effects of health and disease conditions in defined populations. This epidemiology of parasite infectious diseases is predominantly studied in human populations but also spans other major hosts of parasitic infections and as such this journal will have a broad remit. We will focus on the major areas of epidemiological study including disease etiology, disease surveillance, drug resistance and geographical spread and screening, biomonitoring, and comparisons of treatment effects in clinical trials for both human and other animals. We will also look at the epidemiology and control of vector insects. The journal will also cover the use of geographic information systems (EpiGIS) for epidemiological surveillance which is a rapidly growing area of research in infectious diseases. Molecular epidemiological approaches are also particularly encouraged. The primary form of publication in the journal is a full-length paper describing scientifically-sound original research studies. Less than full-length publications include Brief Communications of original research findings, and Investigative Reports describing studies of unique single cases or widespread outbreaks. Review articles on specific high profile topics, emerging or strategic issues may be solicited by the journal for publication, but requests for such submissions may also be made. Topical review articles based on keynote presentations at conferences or workshops will be considered General enquiries prior to submission should be directed to the Editorial Office: [email protected] BEFORE YOU BEGIN Ethics in publishing Please see our information on <a href="/goto?url=https://www.elsevier.com/about/policies/publishing-ethics#Authors" target="_blank">Ethics in publishing</a>. Studies involving animal experiments must meet the International Guiding Principles for Biomedical Research Involving Animals as issued by the Council for International Organizations of Medical Sciences. (Obtainable from: Executive Secretary C.I.O.M.S., c/o W.H.O., Via Appia, CH-1211 Geneva 27, Switzerland). Declaration of interest All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places: 1. A summary declaration of interest statement in the title page file (if double anonymized) or the manuscript file (if single anonymized). If there are no interests to declare then please state this: 'Declarations of interest: none'. 2. Detailed disclosures as part of a separate Declaration of Interest form, which forms part of the journal's official records. It is important for potential interests to be declared in both places and that the information matches. <a href="/goto?url=https://service.elsevier.com/app/answers/detail/a_id/286/supporthub/publishing/" target="_blank">More information</a>. Submission declaration and verification Submission of an article implies that the work described has not been published previously (except in the form of an abstract, a published lecture or academic thesis, see '<a href="/goto?url=https://www.elsevier.com/about/policies/publishing-ethics#Authors" target="_blank">Multiple, redundant or concurrent </a><a href="/goto?url=https://www.elsevier.com/about/policies/publishing-ethics#Authors" target="_blank">publication</a>' for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyrightholder. To verify originality, your article may be checked by the originality detection service <a href="/goto?url=https://www.elsevier.com/editors/perk/plagiarism-complaints/plagiarism-detection" target="_blank">Crossref </a><a href="/goto?url=https://www.elsevier.com/editors/perk/plagiarism-complaints/plagiarism-detection" target="_blank">Similarity Check</a>. Use of inclusive language Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Content should make no assumptions about the beliefs or commitments of any reader; contain nothing which might imply that one individual is superior to another on the grounds of age, gender, race, ethnicity, culture, sexual orientation, disability or health condition; and use inclusive language throughout. Authors should ensure that writing is free from bias, stereotypes, slang, reference to dominant culture and/or cultural assumptions. We advise to seek gender neutrality by using plural nouns ("clinicians, patients/clients") as default/wherever possible <ul style="display: flex;"><li style="flex:1">AUTHOR INFORMATION PACK 27 Sep 2021 </li><li style="flex:1"><a href="/goto?url=http://www.elsevier.com/locate/parepi" target="_blank">www.elsevie</a><a href="/goto?url=http://www.elsevier.com/locate/parepi" target="_blank">r</a><a href="/goto?url=http://www.elsevier.com/locate/parepi" target="_blank">.</a><a href="/goto?url=http://www.elsevier.com/locate/parepi" target="_blank">com/locate/parepi </a></li><li style="flex:1">4</li></ul>to avoid using "he, she," or "he/she." We recommend avoiding the use of descriptors that refer to personal attributes such as age, gender, race, ethnicity, culture, sexual orientation, disability or health condition unless they are relevant and valid. These guidelines are meant as a point of reference to help identify appropriate language but are by no means exhaustive or definitive. Changes to authorship Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal Editor. To request such a change, the Editor must receive the following from the corresponding author: (a) the reason for the change in author list and (b) written confirmation (e-mail, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed. Only in exceptional circumstances will the Editor consider the addition, deletion or rearrangement of authors after the manuscript has been accepted. While the Editor considers the request, publication of the manuscript will be suspended. If the manuscript has already been published in an online issue, any requests approved by the Editor will result in a corrigendum. Upon acceptance of an article, authors will be asked to complete an 'Exclusive License Agreement' where authors will retain copyright (for more information on this see <a href="/goto?url=https://www.elsevier.com/OAauthoragreement" target="_blank">https://www.elsevie</a><a href="/goto?url=https://www.elsevier.com/OAauthoragreement" target="_blank">r</a><a href="/goto?url=https://www.elsevier.com/OAauthoragreement" target="_blank">.</a><a href="/goto?url=https://www.elsevier.com/OAauthoragreement" target="_blank">com/OAauthoragreement</a>.). Permitted reuse of open access articles is determined by the author's choice of user license (see <a href="/goto?url=https://www.elsevier.com/openaccesslicenses" target="_blank">https://www.elsevie</a><a href="/goto?url=https://www.elsevier.com/openaccesslicenses" target="_blank">r</a><a href="/goto?url=https://www.elsevier.com/openaccesslicenses" target="_blank">.</a><a href="/goto?url=https://www.elsevier.com/openaccesslicenses" target="_blank">com/openaccesslicenses</a>). Retained author rights As an author you (or your employer or institution) retain certain rights, including copyright; for details you are referred to <a href="/goto?url=https://www.elsevier.com/OAauthoragreement" target="_blank">https://www.elsevie</a><a href="/goto?url=https://www.elsevier.com/OAauthoragreement" target="_blank">r</a><a href="/goto?url=https://www.elsevier.com/OAauthoragreement" target="_blank">.</a><a href="/goto?url=https://www.elsevier.com/OAauthoragreement" target="_blank">com/OAauthoragreement</a>. Elsevier supports responsible sharing Find out how you can <a href="/goto?url=https://www.elsevier.com/authors/journal-authors/submit-your-paper/sharing-and-promoting-your-article" target="_blank">share your research </a>published in Elsevier journals. You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this should be stated. Elsevier has established agreements and developed policies to allow authors whose articles appear in journals published by Elsevier, to comply with potential manuscript archiving requirements as specified as conditions of their grant awards. To learn more about existing agreements and policies please visit <a href="/goto?url=https://www.elsevier.com/fundingbodies" target="_blank">https://www.elsevie</a><a href="/goto?url=https://www.elsevier.com/fundingbodies" target="_blank">r</a><a href="/goto?url=https://www.elsevier.com/fundingbodies" target="_blank">.</a><a href="/goto?url=https://www.elsevier.com/fundingbodies" target="_blank">com/fundingbodies</a>. Open access Please visit our <a href="/goto?url=https://www.elsevier.com/journals/parasite-epidemiology-and-control/2405-6731/open-access-journal" target="_blank">Open Access page </a>for more information. This journal is fully open access; all articles will be immediately and permanently free for everyone to read and download upon publication. Permitted (re)use is defined by your choice of one of the following Creative Commons user licenses (see <a href="/goto?url=https://www.elsevier.com/about/policies/open-access-licenses" target="_blank">https://www.elsevie</a><a href="/goto?url=https://www.elsevier.com/about/policies/open-access-licenses" target="_blank">r</a><a href="/goto?url=https://www.elsevier.com/about/policies/open-access-licenses" target="_blank">.</a><a href="/goto?url=https://www.elsevier.com/about/policies/open-access-licenses" target="_blank">com/about/policies/open-access-licenses</a>): Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative Bworks of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation. Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND): for noncommercial purposes, lets others distribute and copy the article, and to include in a collective work (such as an anthology), as long as they credit the author(s) and provided they do not alter or modify the article. <ul style="display: flex;"><li style="flex:1">AUTHOR INFORMATION PACK 27 Sep 2021 </li><li style="flex:1"><a href="/goto?url=http://www.elsevier.com/locate/parepi" target="_blank">www.elsevie</a><a href="/goto?url=http://www.elsevier.com/locate/parepi" target="_blank">r</a><a href="/goto?url=http://www.elsevier.com/locate/parepi" target="_blank">.</a><a href="/goto?url=http://www.elsevier.com/locate/parepi" target="_blank">com/locate/parepi </a></li><li style="flex:1">5</li></ul>To provide open access, this journal has an open access fee (also known as: open access publication fee) which needs to be met by the authors or their research funders. The open access fee is all inclusive, Elsevier will not add any additional charges. Depending on local regulations VAT can be charged by local authorities.

Parasite Epidemiology and Control

Details

Download

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

Support